Northera 100 MG capsule 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FSHC4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,110
Award facts
- Contract value 100% obligated
- $9,110.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,110.25 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Northera 100 mg capsules (90-count units). The award, issued on January 15, 2026, with an ultimate completion date of February 6, 2026, utilizes firm fixed-price pricing and includes no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. will perform this delivery order at its Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499,999,999 ceiling value and completion date of December 31, 2036. The PPV-G GEN V program, part of a broader $30.3 billion acquisition strategy, establishes multiple regional prime vendor contractors to supply pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous previous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system, with no subcontractors identified on this award.
Quick answers
Who was awarded contract SPE2DR26FSHC4?
SPE2DR26FSHC4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FSHC4 worth?
The government has obligated $9,110 on SPE2DR26FSHC4.
Is contract SPE2DR26FSHC4 an order under another contract?
Yes. SPE2DR26FSHC4 is a delivery order under SPE2DR25D9305, an indefinite delivery contract.
Was contract SPE2DR26FSHC4 competed?
The extent of competition for SPE2DR26FSHC4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award